Fields »
ABOUT
HELP
BLOG

552 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
CRHR2Corticotropin releasing hormone receptor 2N/A
Tissue enhancedseminal vesicle:1.8
CX3CR1Chemokine (C-X3-C motif) receptor 1
Tissue enhancedcerebral cortex:59.4
CXCR1Chemokine (C-X-C motif) receptor 1
Tissue enhancedappendix:35.7
spleen:25.4
CXCR2Chemokine (C-X-C motif) receptor 2
Tissue enhancedappendix:56.9
spleen:37.2
CXCR3Chemokine (C-X-C motif) receptor 3
Renal cancer: 1.67e-6
Endometrial cancer: 3.44e-6
Melanoma: 2.90e-4
Head and neck cancer: 3.35e-4
Tissue enhancedlymph node:18.1
CXCR5Chemokine (C-X-C motif) receptor 5
Tissue enhancedlymph node:32.9
spleen:21.7
tonsil:16.2
CXCR6Chemokine (C-X-C motif) receptor 6N/A
Endometrial cancer: 6.74e-6
Renal cancer: 2.42e-5
Head and neck cancer: 2.16e-4
Cervical cancer: 4.92e-4
Mixed
CYBBCytochrome b-245, beta polypeptide
Tissue enhancedappendix:221.1
CYSLTR1Cysteinyl leukotriene receptor 1
Mixed
CYSLTR2Cysteinyl leukotriene receptor 2
Tissue enhancedplacenta:36.4
seminal vesicle:24.8
DCST1DC-STAMP domain containing 1N/A
Group enriched5skin:3.7
testis:6.2
DRD1Dopamine receptor D1N/A
Tissue enhancedcerebral cortex:8.0
DRD2Dopamine receptor D2
Tissue enriched5adrenal gland:11.3
DRD5Dopamine receptor D5
Tissue enhancedappendix:1.8
cerebral cortex:2.0
stomach:3.7
DUOX1Dual oxidase 1
Cervical cancer: 4.31e-6
Tissue enhancedskin:96.8
thyroid gland:92.3
EDNRAEndothelin receptor type A
Renal cancer: 1.50e-7
Stomach cancer: 3.93e-4
Tissue enhancedseminal vesicle:145.4
EDNRBEndothelin receptor type B
Plasma membrane
Cytosol		Renal cancer: 7.20e-5
Tissue enhancedplacenta:178.8
ELOVL1ELOVL fatty acid elongase 1
Endoplasmic reticulumLiver cancer: 2.79e-7
Cervical cancer: 3.63e-5
Pancreatic cancer: 8.51e-4
Expressed in all
ELOVL3ELOVL fatty acid elongase 3
Vesicles
Cytosol		Endometrial cancer: 6.25e-5
Tissue enhancedadipose tissue:3.6
breast:4.4
skin:3.4
ELOVL5ELOVL fatty acid elongase 5
Endoplasmic reticulumRenal cancer: 1.94e-6
Thyroid cancer: 6.80e-4
Expressed in all
ELOVL6ELOVL fatty acid elongase 6
Colorectal cancer: 6.74e-4
Mixed
ELOVL7ELOVL fatty acid elongase 7
Renal cancer: 1.54e-9
Endometrial cancer: 3.87e-5
Mixed
F2RCoagulation factor II (thrombin) receptor
Renal cancer: 2.21e-7
Expressed in all
F2RL1Coagulation factor II (thrombin) receptor-like 1
Plasma membraneRenal cancer: 5.86e-7
Colorectal cancer: 3.88e-4
Head and neck cancer: 5.88e-4
Lung cancer: 8.92e-4
Mixed
FAIM2Fas apoptotic inhibitory molecule 2
Intermediate filamentsTissue enriched7cerebral cortex:370.8
FFAR2Free fatty acid receptor 2
Tissue enhancedappendix:26.2
bone marrow:13.4
FFAR3Free fatty acid receptor 3
Tissue enhancedadipose tissue:2.5
appendix:3.6
smooth muscle:2.2
FFAR4Free fatty acid receptor 4N/A
Plasma membraneTissue enhancedcolon:8.6
rectum:12.9
FLVCR1Feline leukemia virus subgroup C cellular receptor 1
Cell JunctionsRenal cancer: 1.06e-5
Liver cancer: 2.52e-5
Pancreatic cancer: 3.50e-4
Tissue enhancedsmall intestine:21.9
FLVCR2Feline leukemia virus subgroup C cellular receptor family, member 2
Renal cancer: 2.53e-5
Tissue enhancedtestis:38.5
FPR1Formyl peptide receptor 1
Nucleus
Nucleoli
Golgi apparatus		Renal cancer: 2.21e-4
Tissue enhancedappendix:181.6
FPR2Formyl peptide receptor 2
Tissue enhancedappendix:71.3
FZD10Frizzled class receptor 10
N/A
NucleoplasmEndometrial cancer: 5.05e-7
Tissue enhancedcervix, uterine:9.3
esophagus:8.8
FZD2Frizzled class receptor 2
Nuclear bodies
Cell Junctions		Mixed
FZD3Frizzled class receptor 3
Nucleoplasm
Vesicles		Colorectal cancer: 1.17e-4
Ovarian cancer: 3.71e-4
Mixed
FZD4Frizzled class receptor 4
Nucleoplasm
Plasma membrane
Cytosol		Renal cancer: 8.60e-5
Tissue enhancedadipose tissue:127.0
FZD5Frizzled class receptor 5
Mixed
FZD6Frizzled class receptor 6
Plasma membranePancreatic cancer: 1.20e-6
Mixed
FZD7Frizzled class receptor 7
NucleoplasmLiver cancer: 7.71e-5
Mixed
FZD8Frizzled class receptor 8
Endoplasmic reticulumPancreatic cancer: 8.21e-4
Tissue enhancedspleen:16.2
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1
CentrosomeRenal cancer: 3.77e-10
Pancreatic cancer: 2.54e-5
Tissue enhancedcerebral cortex:20.9
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2
Tissue enriched19cerebral cortex:88.4
GALR2Galanin receptor 2
Tissue enhancedsmooth muscle:2.4
GCGRGlucagon receptor
Golgi apparatusGroup enriched7adrenal gland:6.6
kidney:8.5
liver:20.9
parathyroid gland:9.4
GGCXGamma-glutamyl carboxylase
Endometrial cancer: 1.82e-6
Expressed in all
GHSRGrowth hormone secretagogue receptorN/A
Not detected
GIPRGastric inhibitory polypeptide receptor
Tissue enhancedstomach:22.6
GLP2RGlucagon-like peptide 2 receptor
Plasma membraneTissue enhancedgallbladder:19.4
GNRHRGonadotropin-releasing hormone receptor
Tissue enhancedparathyroid gland:1.2
GPBAR1G protein-coupled bile acid receptor 1
Tissue enhancedgallbladder:27.0
smooth muscle:13.8

« prev | Page of 12 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.